Lower prices for first 10 Part D drugs selected for Medicare price negotiations are set to cut seniors' out-of-pocket costs ...
TipRanks on MSN
Elanco price target raised to $22 from $18 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Elanco (ELAN) to $22 from $18 and keeps an Equal Weight rating on the shares. For healthcare ...
Eli Lilly (LLY) stock is in focus as the company posts late-stage trial data to indicate that its obesity pill orforglipron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback